Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

China Health Industries Holdings Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of China Health Industries Holdings Inc (CHHE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2024
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-99.59 %
Q3 2024
Net Margin
-164,082.76 %
Q3 2024

Key Findings: China Health Industries Holdings Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 0M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-99.4% annualized vs trailing 12 months).
  • Scale: China Health Industries Holdings Inc ranks #494 of 544 companies by market capitalization in the Major Pharmaceutical Preparations industry, holding 0.0% of industry market cap.
  • Peer revenue share: China Health Industries Holdings Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

CHHE Sales vs. its Competitors, Q3 2024

China Health Industries Holdings Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CHHE/competitors
https://api.csimarket.com/api/v1/companies/CHHE/relationships
https://api.csimarket.com/api/v1/companies/CHHE/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs -99.6% for China Health Industries Holdings Inc. China Health Industries Holdings Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

China Health Industries Holdings Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
China Health Industries Holdings Inc No No No Yes
Similar-Size Competitors (9) 0% 50% 50% 78%
Similar Growth & Profitability (8) 0.00 % (0 of 8) 25.00 % (2 of 8) 25.00 % (2 of 8) 75.00 % (6 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2024

100%market share
  • China Health Industries Holdings Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of China Health Industries Holdings Inc and its 0 tracked competitors.

See China Health Industries Holdings Inc's full market share breakdown »

CHHE Stock Performance relative to its Competitors

CHHE Competitors (weighted) Percent change over the selected range

China Health Industries Holdings Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
Similar-Size
(0 of 2)
33.3%beat U.S.A. 500
Similar Growth & Profitability
(1 of 3)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
China Health Industries Holdings Inc - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (2) 40.4% 63.2%
Similar Growth & Profitability (3) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for China Health Industries Holdings Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

CHHE Stock Performance relative to Similar-Size Competitors

CHHE Similar-Size Competitors (equal-weighted, 9) Percent change over the selected range

CHHE Stock Performance relative to Similar Growth & Profitability Competitors

CHHE Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range